378 related articles for article (PubMed ID: 15806153)
1. Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells.
Mukherjee K; Syed V; Ho SM
Oncogene; 2005 Jun; 24(27):4388-400. PubMed ID: 15806153
[TBL] [Abstract][Full Text] [Related]
2. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells.
Syed V; Ulinski G; Mok SC; Yiu GK; Ho SM
Cancer Res; 2001 Sep; 61(18):6768-76. PubMed ID: 11559549
[TBL] [Abstract][Full Text] [Related]
3. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL.
Syed V; Ho SM
Oncogene; 2003 Oct; 22(44):6883-90. PubMed ID: 14534535
[TBL] [Abstract][Full Text] [Related]
4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
5. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells.
Syed V; Zhang X; Lau KM; Cheng R; Mukherjee K; Ho SM
Oncogene; 2005 Dec; 24(55):8128-43. PubMed ID: 16116479
[TBL] [Abstract][Full Text] [Related]
6. Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling.
Syed V; Mukherjee K; Lyons-Weiler J; Lau KM; Mashima T; Tsuruo T; Ho SM
Oncogene; 2005 Mar; 24(10):1774-87. PubMed ID: 15674352
[TBL] [Abstract][Full Text] [Related]
7. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
Ho SM; Lau KM; Mok SC; Syed V
Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
[TBL] [Abstract][Full Text] [Related]
8. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
9. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S
Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
[TBL] [Abstract][Full Text] [Related]
10. Effects of pharmacological concentrations of estrogens on growth of 3AO human ovarian cancer cells.
Li ZB; Chen YX; Zhao JY; Lu J
Yi Chuan Xue Bao; 2006 Sep; 33(9):782-92. PubMed ID: 16980124
[TBL] [Abstract][Full Text] [Related]
11. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.
De Sousa Damião R; Fujiyama Oshima CT; Stávale JN; Gonçalves WJ
Oncol Rep; 2007 Jul; 18(1):25-32. PubMed ID: 17549341
[TBL] [Abstract][Full Text] [Related]
13. Selective and opposing actions of progesterone receptor isoforms in human endometrial stromal cells.
Yudt MR; Berrodin TJ; Jelinsky SA; Hanna LA; Brown EL; Chippari S; Bhat RA; Winneker RC; Zhang Z
Mol Cell Endocrinol; 2006 Mar; 247(1-2):116-26. PubMed ID: 16442706
[TBL] [Abstract][Full Text] [Related]
14. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
[TBL] [Abstract][Full Text] [Related]
15. Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
Zheng ZY; Zheng SM; Bay BH; Aw SE; C-L Lin V
Breast Cancer Res Treat; 2008 Jul; 110(1):111-25. PubMed ID: 17687644
[TBL] [Abstract][Full Text] [Related]
16. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
17. Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells.
Kang SK; Choi KC; Tai CJ; Auersperg N; Leung PC
Endocrinology; 2001 Feb; 142(2):580-8. PubMed ID: 11159828
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.
Runnebaum IB; Brüning A
Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
20. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
Zheng ZY; Lin VC
Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]